Can community-based interventions help to close the epilepsy treatment gap?

More than 50 million people have epilepsy; about 80% live in lower- or middle-income countries, where diagnosis and treatment can be difficult or impossible. The percentage of people with epilepsy that is not receiving treatment is known as the treatment gap; in some countries, this gap exceeds 90%.

Read more

Suspended studies and virtual lab meetings: How the COVID-19 pandemic is affecting epilepsy researchers

How was epilepsy research forced to morph during the first few months of the COVID-19 pandemic? Researchers from 11 countries shared their experiences and thoughts on the future of laboratory research, clinical trials, and in-person conferences.

Read more

When seizures don’t stop: What’s the latest in treating status epilepticus?

When seizures last longer than about 5 minutes–a condition called status epilepticus–emergency treatment is required. About two-thirds of people respond to initial treatment with benzodiazepines, but the others need a second drug. Which drug to choose is a matter of some debate.

Read more